Focus:
Catalent announced plans to expand its biologics manufacturing facility in Bloomington, Indiana, US
Catalent announced plans to expand its biologics manufacturing facility in Bloomington, Indiana, US
Read More...
The Centre for Process Innovation (CPI), the University of Strathclyde, Scottish Enterprise, Innovate UK, AstraZeneca...
Read More...
Meissner Filtration Products is developing a new manufacturing facility in County Mayo, Castlebar, Ireland.
Read More...
Eirgenix, a Taiwanese contract development and manufacturing organisation (CDMO), is developing a new protein drug...
Read More...
Fujifilm Diosynth Biotechnologies is expanding its existing BioProcess Innovation Center in North Carolina, US.
Read More...
In October 2018, Experic announced plans to develop a new manufacturing and packaging facility in...
Read More...
Saudi Vaccine and Biomanufacturing Centre is a research facility being constructed at the KAUST Research...
Read More...
In April 2018, Porton Biopharma Limited (PBL) opened a new pharmaceutical fermentation facility at the...
Read More...
In the second half of 2018, Minakem opened a new high-containment production facility in Louvain-la-Neuve,...
Read More...
Lonza and GE Healthcare are developing a new biologics facility in Guangzhou, China.
Read More...
